Accelerate your knowledge of trends, decision-drivers and emerging themes in payer assessments with IQVIA's HTA Accelerator. With HTA Accelerator, you can have direct insight into payer decisions and requirements and advanced analytic capabilities to guide market access strategy from research to launch to market expansion.
HTA Accelerator shows you payer requirements by market, disease or product category. It delivers a nuanced understanding of the dynamic payer environment based on HTA reports of more than 100 agencies in 32 countries. With new drugs coming to market every month, it also provides near real-time data on recent product submissions that could affect your future plans.
HTA Accelerator gives you direct access to payer insights, based on regulatory approvals, clinical trials, pricing, policy updates and country and agency information, including
Now you can shape trial design using the type of data that payers in your market are asking for. You can review regulatory reporting for relevant products to understand the role of real world evidence in positive assessments. For products in market, you can monitor payer assessments that could impact future reimbursement and pricing for your product.
You can use HTA Accelerator as a standalone software platform to give your team simple access to payer information. You can work with IQVIA experts to identify trends, design research or perform in-depth patient and market reviews.
HTA Accelerator services can include
HTA Accelerator is part of IQVIA's Pricing and Market Access solutions, which integrate pricing, launch planning and other IQVIA offerings into a customized approach based on your product development needs.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.
Learn more about the federated evidence networks and massive, non-identified global databases that inform our real world solutions.
Use emerging data sources and advances in evidence methods to demonstrate product value and safety.
Automate and customize data analysis and get the most out of your portfolio with scalable platforms.
Tap into evidence networks in oncology, neurology, immunology, and other therapy areas to enrich your studies.
Access clearer, more compelling support to demonstrate the value of your product.